TRCT
RNA

Tower Research Capital (TRC)’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Tower Research Capital (TRC)’s Portfolio RNA Stock Details RNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-647
Closed -$12K – 5498
2014
Q4 		$12K Buy
647
+162
+33% +$2.3K ﹤0.01% 2038
2014
Q3 		$4K Sell
485
-100
-17% -$948 ﹤0.01% 3548
2014
Q2 		$7K Sell
585
-301
-34% -$2.44K ﹤0.01% 2679
2014
Q1 		$5K Sell
886
-2,914
-77% -$18.1K ﹤0.01% 3363
2013
Q4 		$18K Buy
+3,800
New +$17.3K ﹤0.01% 2475

Tower Research Capital (TRC)'s RNA Position: Q1 2015 in Review

Tower Research Capital (TRC) sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q1 2015, closing a stake of 647 shares — an estimated $12K sold.

Tower Research Capital (TRC) first reported a position in RNA in Q4 2013 and held it in 5 quarters. The position peaked at $18K in Q4 2013. 0 funds tracked by Wall St. Rank hold RNA as of Q1 2015.

  • Tower Research Capital (TRC) reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q1 2015 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 647 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q1 2015, an estimated $12K.
  • Tower Research Capital (TRC) first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q4 2013 and held it in 5 quarters.
  • Tower Research Capital (TRC)'s PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $18K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q1 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2015, filed 12 May 2015.